美国临床生化科学院(NACB)于1999年7月发表了关于冠状动脉疾病心脏标志物应用的检验医学实践指南(LMPG)。自从这最初的文件问世以来,许多发表的研究成果和呈现的数据都显著地更新增加了心脏生物标志物的知识库。这些新知识已经从实质上扩展了1999年文件所推荐的心脏生物标志物? The American College of Clinical Biochemistry (NACB) published the Inspecting Practice in Medicine (LMPG) in July 1999 on the application of cardiac markers of coronary artery disease. Since the publication of this initial document, many published research and presented data have dramatically updated the knowledge base that has added cardiac biomarkers. These new knowledge have substantially expanded the cardiac biomarkers recommended in the 1999 document?